Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03829397
Other study ID # TYGH107037
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 18, 2019
Est. completion date March 24, 2020

Study information

Verified date May 2019
Source Taoyuan General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aim to clarify the participants's mental state with Demoralization Scale- Mandarin Version(DS-MV). Based on clinical observations and literature review, investigators assume participants's DS-MV score high correlation with PHQ-9 score.


Description:

The Chinese version of Demoralization Scale-Mandarin Version (DS-MV) was used to assess the mental state of patients with stroke after debridement. The statistical analysis test of correlation is carried out, and the reliability and validity test and the norm establishment of the Chinese version are further tested. Convenient sampling will be performed at a single medical facility. The planned implementation period is 2019/01/01 ~ 2019/12/31, and the location of the case is the rehabilitation ward and outpatient clinic of Taoyuan Hospital. The diagnosis must be: intensive stroke or hemorrhagic brain within three years. In the case of a 20- to 100-year-old clinical patient with stroke, the subject should explain the content of the case, and the subject will complete the test consent form after informed consent, and then begin the evaluation process of the self-assessment questionnaire. The assessment procedure is preceded by a clinical psychologist conducting with MMSE test to determine the cognitive function. When the patient's consciousness is blurred, the simple intelligent state test (MMSE) score less than 24 points, aphasia can not be effectively communicated, the diagnosis of mental illness or mental disorder has been recorded on the medical record, or the patient or family member is unwilling to sign the informed consent form. If the above situation is met, subjects will be excluded. The self-assessment questionnaire will obtain the scores of the subjects in the Chinese version of the Demoralization Scale-Mandarin Version (DS-MV) and the Patient Health Questionnaire (PHQ-9). Statistical analysis, as well as the Chinese version of the loss of the scale of the reliability and validity of the test and the establishment of clinical norm scores.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date March 24, 2020
Est. primary completion date March 24, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 100 Years
Eligibility Inclusion Criteria:

- Inpatient and outpatient of rehabilitation department in Taoyuan General Hospital, patients diagnosis : who have an infarct stroke or hemorrhagic stroke within three years.

Exclusion Criteria:

- Conscious state confusion, the MMSE score less than 24.

- Unable to understand information, speech disorders, dementia, aphasia.

- The diagnosis of mental illness or mental disorder has been recorded on the medical history.

- The patient or family unwilling to sign an informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Questionnaire
Questionnaire

Locations

Country Name City State
Taiwan Tao-Yuan General Hospital Taoyuan City Zhongshan Rd., Taoyuan Dist

Sponsors (1)

Lead Sponsor Collaborator
Taoyuan General Hospital

Country where clinical trial is conducted

Taiwan, 

References & Publications (7)

Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry. 2002 Dec;36(6):733-42. Review. — View Citation

Julião M, Nunes B, Barbosa A. Prevalence and factors associated with demoralization syndrome in patients with advanced disease: Results from a cross-sectional Portuguese study. Palliat Support Care. 2016 Oct;14(5):468-73. doi: 10.1017/S1478951515001364. Epub 2016 Jan 6. — View Citation

Mangelli L, Semprini F, Sirri L, Fava GA, Sonino N. Use of the Diagnostic Criteria for Psychosomatic Research (DCPR) in a community sample. Psychosomatics. 2006 Mar-Apr;47(2):143-6. — View Citation

Nanni MG, Caruso R, Travado L, Ventura C, Palma A, Berardi AM, Meggiolaro E, Ruffilli F, Martins C, Kissane D, Grassi L. Relationship of demoralization with anxiety, depression, and quality of life: A Southern European study of Italian and Portuguese cancer patients. Psychooncology. 2018 Nov;27(11):2616-2622. doi: 10.1002/pon.4824. Epub 2018 Aug 6. — View Citation

Robinson S, Kissane DW, Brooker J, Burney S. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research. J Pain Symptom Manage. 2015 Mar;49(3):595-610. doi: 10.1016/j.jpainsymman.2014.07.008 — View Citation

Tang PL, Wang HH, Chou FH. A Systematic Review and Meta-Analysis of Demoralization and Depression in Patients With Cancer. Psychosomatics. 2015 Nov-Dec;56(6):634-43. doi: 10.1016/j.psym.2015.06.005. Epub 2015 Jun 19. Review. — View Citation

Wu YC, Tung HH, Wei J. Quality of life, demoralization syndrome and health-related lifestyle in cardiac transplant recipients - a longitudinal study in Taiwan. Eur J Cardiovasc Nurs. 2019 Feb;18(2):149-162. doi: 10.1177/1474515118800397. Epub 2018 Sep 18. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary demoralization Scale-Mandarin Version (DS-MV) total score When participants was included, investigators get on one-time assessment use the demoralization Scale-Mandarin Version (DS-MV). The demoralization Scale-Mandarin Version (DS-MV) minimum score are 0, and maximum score are 96, cut-off point are 30. No subscale. through study completion, an average of 1 year
Secondary demoralization Scale-Mandarin Version (DS-MV) total score split-half reliability Divide the demoralization Scale-Mandarin Version (DS-MV) into half, and then test the items of the previous half (item 1-12) and the second half (item 13-24) of the questionnaire. Then the two half questionnaire scores were test of correlation coefficient.Then If the degree of correlation is high, the reliability is very high. through study completion, an average of 1 year
Secondary Patient Health Questionnaire (PHQ-9) total score When participants was included, investigators get on one-time assessment use the Patient Health Questionnaire (PHQ-9) .Patient Health Questionnaire (PHQ-9) minimum score are 0, and maximum score are 27. No subscale. through study completion, an average of 1 year
Secondary demoralization Scale-Mandarin Version (DS-MV) total score criterion-related validity Correlation test between demoralization Scale-Mandarin Version (DS-MV) total score and Patient Health Questionnaire(PHQ-9) total score. through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05612659 - Developing an EEG Probe for Studying and Modulating Cognitive Control N/A
Completed NCT04093843 - TMS for Post Stroke Depression N/A
Recruiting NCT05516680 - Effects and Central Mechanism of Electroacupuncture and MRI-navigated rTMS for PSD N/A
Recruiting NCT04876066 - Use of Transmucosal Ketamine in Post Stroke Depression Phase 1
Recruiting NCT03159351 - The Antidepressant Effects of rTMS After Ischemic Stroke N/A
Recruiting NCT03864484 - iPad Application-based Intervention for Post-stroke Depression N/A
Recruiting NCT05310175 - Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression N/A
Completed NCT03639259 - Emotional and Cognitive Determinants of Post-stroke Fatigue
Completed NCT02472613 - Acupuncture for Ischemic Post-stroke Depression N/A
Completed NCT04008719 - ATtention Test and Executive Functions After STroke to Predict Depression. N/A
Recruiting NCT05241782 - The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients N/A
Withdrawn NCT03761303 - rTMS as an add-on Therapy in Patients With Post-stroke Depression N/A
Completed NCT04318951 - Impact of Intensive Social Interaction on Post-Stroke Depression in Individuals With Aphasia N/A
Completed NCT04560413 - Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients
Recruiting NCT05187975 - Integrated Rehabilitation in Treating Post-stroke Depression N/A
Completed NCT06157333 - Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation on Patients With Post-stroke Depression N/A
Recruiting NCT03256305 - A Study of rTMS Personalized Precision Treatment of Post-stroke Depression N/A
Recruiting NCT03789994 - Affective Touching on Poststroke Depression N/A
Completed NCT05932550 - Safety of Maraviroc for Post-stroke Depression Phase 2
Recruiting NCT03903068 - Transcranial Alternating Current Stimulation Treating Post-stroke Depression N/A